Xtra Iron
Natural health product licensed in Canada
- Other names
- Neobourne Pharma Xtra Iron
- Licence holder
- BIOVANTEK
- NPN or DIN-HM
- 80020628
- Status
- Inactive licence
- Licence date
- 8 July 2010
- Revision date
- 17 May 2022
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Fer: up to 44.94 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 14 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Fer: up to 44.94 mg a day according to the dosing instructions published by Health Canada, above the niveau de sécurité from EFSAEuropean Food Safety Authority. for adults (40 mg a day). Son dépassement ne permet pas, à lui seul, de caractériser un risque : l'EFSA n'a pas pu fixer de limite supérieure pour ce nutriment. Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
niveau de sécurité. EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Fer Source : Gluconate ferreux | 22.47 mg | 44,940 µg |
Non-medicinal ingredients
Stéarate de magnésium, Gélatine, Cellulose, Croscarmellose de sodium, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
| Adolescents | minimum: 14 years ; maximum: 18 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Aide à formation de globules et à leur bon fonctionnement. Contribue au maintien d'une bonne santé. Aide à fournir aux femmes enceintes l'apport recommandé (par l'«Institute of Medecine») en fer dans le cadre d'une alimentation saine. Aide à prévenir une carence en fer. Aide à prévenir l'anémie ferriprive.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80020628
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging